Roggeri, D. P., Zanon, E. and Roggeri, A. (2017) “Recently approved recombinant factor VIII (rFVIII) for the replacement treatment in patients with hemophilia A in Italy”, Farmeconomia. Health economics and therapeutic pathways, 18(1). doi: 10.7175/fe.v18i1.1321.